Healthcare
Health
Medical

DaVita

$54.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-0.37%) Today
+$0.54 (1.01%) After Hours

Why Robinhood?

You can buy or sell DaVita and other stocks, options, ETFs, and crypto commission-free!

About

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. Read More The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Employees
77,700
Headquarters
Denver, Colorado
Founded
1994
Market Cap
8.97B
Price-Earnings Ratio
67.56
Dividend Yield
0.00
Average Volume
1.62M
High Today
$54.54
Low Today
$52.83
Open Price
$53.86
Volume
695.00K
52 Week High
$79.11
52 Week Low
$48.25

Collections

Healthcare
Health
Medical
US
North America

News

TradingNewsNowMar 18

Latest Change: DaVita (NYSE: DVA)

DaVita trades as part of the health care providers industry and is in the healthcare sector. The company CEO is Kent J. Thiry. DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives. Previous Intraday Trading Performance: The DVA stock showed a previous change of -0.09% with an open at 53.60 and a close of 53.53. It reached an intraday high ...

124
Yahoo FinanceMar 15

DaVita HealthCare (DVA) Down 7.8% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for DaVita HealthCare (DVA). Shares have lost about 7.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is DaVita HealthCare due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. DaVita Q4 Earnings Beat on Increasing D...

68
Yahoo FinanceMar 13

How Good Is DaVita Inc. (NYSE:DVA), When It Comes To ROE?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important.

64

Earnings

$0.56
$0.72
$0.89
$1.05
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 2, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.